GABELLI FUNDS LLC - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2022$241,000
-38.4%
28,000
-41.7%
0.00%
-33.3%
Q2 2022$391,000
-34.0%
48,000
-1.4%
0.00%
-25.0%
Q1 2022$592,000
-61.2%
48,700
+8.9%
0.00%
-60.0%
Q4 2021$1,525,000
-29.3%
44,7000.0%0.01%
-28.6%
Q3 2021$2,156,000
+4.5%
44,700
-2.2%
0.01%
+7.7%
Q2 2021$2,064,000
-5.3%
45,700
+1.1%
0.01%
-13.3%
Q1 2021$2,180,000
-32.2%
45,200
-24.4%
0.02%
-34.8%
Q4 2020$3,217,000
+32.7%
59,760
-9.0%
0.02%
+21.1%
Q3 2020$2,424,000
-11.6%
65,700
-25.8%
0.02%
-13.6%
Q2 2020$2,742,000
+65.5%
88,500
+47.5%
0.02%
+46.7%
Q1 2020$1,657,000
-19.1%
60,000
-14.3%
0.02%
+15.4%
Q4 2019$2,048,000
+46.7%
70,000
-4.1%
0.01%
+44.4%
Q3 2019$1,396,000
-50.0%
73,000
-42.6%
0.01%
-50.0%
Q2 2019$2,791,000
+2.9%
127,190
-4.1%
0.02%
+5.9%
Q1 2019$2,713,000
+48.7%
132,602
-8.3%
0.02%
+30.8%
Q4 2018$1,824,000
-64.0%
144,624
-56.1%
0.01%
-55.2%
Q3 2018$5,061,000
+6.7%
329,737
-8.9%
0.03%
+3.6%
Q2 2018$4,745,000
-24.3%
361,933
-52.9%
0.03%
-24.3%
Q1 2018$6,267,000
+48.5%
768,000
+61.2%
0.04%
+54.2%
Q4 2017$4,221,000
+3.9%
476,400
+30.5%
0.02%
+4.3%
Q3 2017$4,062,000
-37.3%
365,000
-49.5%
0.02%
-39.5%
Q2 2017$6,478,000
+59.8%
723,014
+40.7%
0.04%
+58.3%
Q1 2017$4,054,000
+195.7%
513,795
+221.1%
0.02%
+200.0%
Q4 2016$1,371,000
+19.1%
160,000
+14.3%
0.01%
+14.3%
Q3 2016$1,151,000
-20.5%
140,000
-22.2%
0.01%
-22.2%
Q2 2016$1,447,000
-51.8%
180,000
-59.6%
0.01%
-50.0%
Q1 2016$2,999,000
+29.2%
445,000
+50.8%
0.02%
+28.6%
Q4 2015$2,322,000
-9.8%
295,000
-34.4%
0.01%
-6.7%
Q3 2015$2,575,000
-15.4%
449,357
-20.2%
0.02%
-6.2%
Q2 2015$3,045,000
-2.7%
562,757
-16.0%
0.02%0.0%
Q1 2015$3,128,000
+31.2%
669,811
+17.1%
0.02%
+33.3%
Q4 2014$2,385,000
-21.8%
572,054
-2.2%
0.01%
-20.0%
Q3 2014$3,048,000
+83.6%
585,000
+17.0%
0.02%
+87.5%
Q2 2014$1,660,000
+74.0%
500,000
+81.8%
0.01%
+60.0%
Q1 2014$954,000
-22.7%
275,000
-19.3%
0.01%
-28.6%
Q4 2013$1,234,000
+32.7%
340,800
+9.9%
0.01%
+40.0%
Q3 2013$930,000
+47.2%
310,000
+95.1%
0.01%
+25.0%
Q2 2013$632,000158,9000.00%
Other shareholders
NEOGENOMICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,046,639$12,8748.15%
Greenhouse Funds LLLP 3,981,003$48,966,3373.62%
First Light Asset Management, LLC 3,028,913$37,255,6303.54%
PERKINS CAPITAL MANAGEMENT INC 193,950$2,3862.36%
EMERALD MUTUAL FUND ADVISERS TRUST 1,557,895$19,162,1091.16%
EMERALD ADVISERS, LLC 1,927,074$23,703,0051.15%
Bullseye Asset Management LLC 163,792$2,0151.12%
FORMULA GROWTH LTD 208,885$2,569,2860.88%
OAK FAMILY ADVISORS, LLC 96,737$1,189,8650.56%
Parkman Healthcare Partners LLC 245,812$3,023,4880.55%
View complete list of NEOGENOMICS INC shareholders